Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug;292(2):377-384.
doi: 10.1111/joim.13504. Epub 2022 May 17.

Adults hospitalized with breakthrough COVID-19 have lower mortality than matched unvaccinated adults

Affiliations

Adults hospitalized with breakthrough COVID-19 have lower mortality than matched unvaccinated adults

Laura C Myers et al. J Intern Med. 2022 Aug.

Abstract

Background: Coronavirus disease 2019 (COVID-19) breakthrough infections are common.

Objective: Evaluate in-hospital mortality of patients with COVID-19 by vaccination status using retrospective cohort study.

Methods: We generated propensity scores for receipt of full vaccination in adults requiring supplemental oxygen hospitalized at Kaiser Permanente Northern California (1 April 2021 to 30 November 2021) with positive severe acute respiratory syndrome coronavirus 2 polymerase chain reaction tests. Optimal matching of fully vaccinated/unvaccinated patients was performed comparing in-hospital mortality.

Results: Of 7305 patients, 1463 (20.0%) were full, 138 (1.9%) were partial, and 5704 (78.1%) were unvaccinated. Fully vaccinated were older than partial or unvaccinated (71.0, 63.0, and 54.0 years, respectively, p < 0.001) with more comorbidities (Comorbidity Point Scores 33.0, 22.0, and 10.0, p < 0.001) and immunosuppressant (11.5%, 8.7%, and 3.0%, p < 0.001) or chemotherapy exposure (2.8%, 0.7%, and 0.4%, p < 0.001). Fewer fully vaccinated patients died compared to matched unvaccinated (9.0% vs. 16.3%, p < 0.0001).

Conclusion: Fully vaccinated patients are less likely to die compared to matched unvaccinated patients.

Keywords: COVID-19; breakthrough infection; hospitalization; mortality; vaccination.

PubMed Disclaimer

Conflict of interest statement

Nicola P. Klein reports research support from Pfizer for COVID vaccine trials and from Pfizer, Merck, Sanofi Pasteur, GlaxoSmithKline, and Protein Science (now Sanofi Pasteur) for unrelated research. Gabriel J. Escobar, Vincent X. Liu, and Laura C. Myers report research support from Astra Zeneca unrelated to vaccine research. The other authors have no conflict of interest.

Similar articles

Cited by

References

    1. Thompson MG, Stenehjem E, Grannis S, Ball SW, Naleway AL, Ong TC, et al. Effectiveness of Covid‐19 vaccines in ambulatory and inpatient care settings. N Engl J Med. 2021;385:1355–71. 10.1056/NEJMoa2110362. - DOI - PMC - PubMed
    1. Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, et al. Efficacy and safety of the mRNA‐1273 SARS‐CoV‐2 vaccine. N Engl J Med. 2021;384(5):403–16. 10.1056/NEJMoa2035389. - DOI - PMC - PubMed
    1. Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and efficacy of the BNT162b2 mRNA covid‐19 vaccine. N Engl J Med. 2020;383(27):2603–15. 10.1056/NEJMoa2034577. - DOI - PMC - PubMed
    1. Sadoff J, Gray G, Vandebosch A, Cárdenas V, Shukarev G, Grinsztejn B, et al. Safety and efficacy of single‐dose Ad26.COV2.S vaccine against covid‐19. N Engl J Med. 2021;384(23):2187–201. 10.1056/NEJMoa2101544. - DOI - PMC - PubMed
    1. Haas EJ, Angulo FJ, Mclaughlin JM, Anis E, Singer SR, Khan F, et al. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS‐CoV‐2 infections and COVID‐19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data. Lancet. 2021;397(10287):1819–29. 10.1016/S0140-6736(21)00947-8. - DOI - PMC - PubMed

Publication types